Cingulate Stock Market Value
| CING Stock | USD 7.70 1.21 18.64% |
| Symbol | Cingulate |
Can Biotechnology industry sustain growth momentum? Does Cingulate have expansion opportunities? Factors like these will boost the valuation of Cingulate. Projected growth potential of Cingulate fundamentally drives upward valuation adjustments. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Cingulate demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Understanding Cingulate requires distinguishing between market price and book value, where the latter reflects Cingulate's accounting equity. The concept of intrinsic value - what Cingulate's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Market sentiment, economic cycles, and investor behavior can push Cingulate's price substantially above or below its fundamental value.
It's important to distinguish between Cingulate's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cingulate should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Cingulate's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Cingulate 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cingulate's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cingulate.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in Cingulate on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding Cingulate or generate 0.0% return on investment in Cingulate over 90 days. Cingulate is related to or competes with Allarity Therapeutics, Lexaria Bioscience, Lixte Biotechnology, Kairos Pharma, Synlogic, CASI Pharmaceuticals, and NuCana PLC. Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the tre... More
Cingulate Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cingulate's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cingulate upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.07 | |||
| Information Ratio | 0.2155 | |||
| Maximum Drawdown | 20.08 | |||
| Value At Risk | (6.75) | |||
| Potential Upside | 8.45 |
Cingulate Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cingulate's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cingulate's standard deviation. In reality, there are many statistical measures that can use Cingulate historical prices to predict the future Cingulate's volatility.| Risk Adjusted Performance | 0.1966 | |||
| Jensen Alpha | 1.17 | |||
| Total Risk Alpha | 0.6279 | |||
| Sortino Ratio | 0.2177 | |||
| Treynor Ratio | 5.34 |
Cingulate February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1966 | |||
| Market Risk Adjusted Performance | 5.35 | |||
| Mean Deviation | 3.53 | |||
| Semi Deviation | 3.86 | |||
| Downside Deviation | 5.07 | |||
| Coefficient Of Variation | 426.16 | |||
| Standard Deviation | 5.12 | |||
| Variance | 26.24 | |||
| Information Ratio | 0.2155 | |||
| Jensen Alpha | 1.17 | |||
| Total Risk Alpha | 0.6279 | |||
| Sortino Ratio | 0.2177 | |||
| Treynor Ratio | 5.34 | |||
| Maximum Drawdown | 20.08 | |||
| Value At Risk | (6.75) | |||
| Potential Upside | 8.45 | |||
| Downside Variance | 25.7 | |||
| Semi Variance | 14.9 | |||
| Expected Short fall | (3.89) | |||
| Skewness | 0.5188 | |||
| Kurtosis | 2.64 |
Cingulate Backtested Returns
Cingulate is slightly risky given 3 months investment horizon. Cingulate secures Sharpe Ratio (or Efficiency) of 0.25, which signifies that the company had a 0.25 % return per unit of risk over the last 3 months. We were able to interpolate twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.32% are justified by taking the suggested risk. Use Cingulate Downside Deviation of 5.07, mean deviation of 3.53, and Risk Adjusted Performance of 0.1966 to evaluate company specific risk that cannot be diversified away. Cingulate holds a performance score of 19 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 0.22, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Cingulate's returns are expected to increase less than the market. However, during the bear market, the loss of holding Cingulate is expected to be smaller as well. Use Cingulate sortino ratio, skewness, price action indicator, as well as the relationship between the potential upside and rate of daily change , to analyze future returns on Cingulate.
Auto-correlation | 0.68 |
Good predictability
Cingulate has good predictability. Overlapping area represents the amount of predictability between Cingulate time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cingulate price movement. The serial correlation of 0.68 indicates that around 68.0% of current Cingulate price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.68 | |
| Spearman Rank Test | 0.69 | |
| Residual Average | 0.0 | |
| Price Variance | 0.79 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out Cingulate Correlation, Cingulate Volatility and Cingulate Performance module to complement your research on Cingulate. For more detail on how to invest in Cingulate Stock please use our How to Invest in Cingulate guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Cingulate technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.